Molecular Medicine and Diagnostics

As science progresses, healthcare is quickly moving near precision medicine, which deals a better understanding of diseases using genetic insights and other  medical developments in technology. Precision medicine, also known as personalised medicine, is an innovative method for disease treatment and prevention that considers the individual inconsistency in genetics, environment, and lifestyle for each patient. This method allows healthcare providers to make a more precise diagnosis and generate specialist treatment plans.   Compared to traditional medicine, precision therapy takes a much more targeted method to drug development. Through widespread research, scientists have learned more about the genetics behind how illnesses start and how they act. By identifying the danger of a patient developing an illness they can be provided with an active prevention plan, decreasing unnecessary misery for patients. This is also valuable to society as it reduces the monetary load of illness an

Molecular modelling  includes all procedures, theoretical and computational, used to model or mimic the activities of molecules. The procedures are used in the areas of computational chemistry, drug design, computational biology and materials science to study molecular systems going from small chemical systems to large biological molecules and material assemblies. Using molecular modelling scientists will be able to design better and new and more powerful drugs against diseases such as Cancer, AIDS, and Arthritis. Molecular modelling not only has the probability to bring fresh drugs to the market, but a huge collection of fresh materials. The discovery of fullerenes, nanotubes and superconducting cuprates, are estimated to produce fresh ingredients in the optics, ceramic, semiconductor and biomaterials markets.

  Next-generation sequencing (NGS) has turned out to be an option for a lot of researchers answering to the possibility of infectious disease epidemics and the present coronavirus pandemic .   The use of NGS technology has skyrocketed in recent years and is getting more approval from the researchers. It is now becoming an important option for most researchers in the battle against the pandemic. COVID-19, a lung disease caused by a novel coronavirus SARS-CoV-2 has quickly swept across the world, contaminating a vast number of people. Early rapid diagnosis is the main weapon in the fight against the virus. NGS has great potential for identifying the nucleic acid sequences of viruses and lets parallel sequencing of a huge amount of DNA fragments in a single test with high precision and a quick turn round time .

  Disease diagnosis and prognosis has enhanced since a long time. As doctors developed their understanding of diseases, they recognised measurable signals, or biomarkers, that show regular biological function, pathology or reaction to treatment. In the previous decade, a new set of technologies have developed that dramatically enhanced the discovery of new biomarkers. The work promises to reshape how doctors analyze and treat disease and how pharmaceutical corporations chase drug development. For instance, in oncology the impacts are already being felt. In the past 18 months, the FDA permitted the first and second tissue-agnostic therapies. For all the services that are driving the molecular medicine and diagnostic research forward, others hold it back. Data is often siloed within administrations or unreachable to the bigger scientific community. It is also often collected with few morals in mind, so researchers cannot blend data sets.